We report the case of a patient with fatal obstructive lung disease after an HLA-haploidentical sibling cord blood transplant (CBT), with severe acute GVHD. A 2-year-old girl developed expiratory air trapping gradually with acute and chronic GVHD after CBT for the treatment of ALL. Anti-CMV and immunosuppressive therapy were ineffective, and the patient died of progressive respiratory acidosis. Necropsy of the lung revealed severe bronchiolitis obliterans with cytomegalic inclusion cells in the granulation tissues of the bronchiolitis. Thus, immunologic and GVHD problems can occur even in CBT. Keywords: obstructive lung disease, bronchiolitis obliterans; CMV; cord blood transplantation; BMT Obstructive lung disease (OLD) is a complication of BMT.
Although some hypotheses of the cause(s) of OLD such as GVHD, opportunistic infection, or preconditioning regimens have been proposed, 3, 4 only rare cases have been examined histologically. Herein, we present a case of fatal OLD after an HLA-haploidentical (2 loci mismatched at HLA-B and DR) sibling CBT, with severe GVHD. The pathologic findings of the necropsied lung are also described.
Case report
A 2-year-old girl was given an HLA-haploidentical sibling CBT for ALL with MLL gene rearrangement after being conditioned with busulfan, etoposide and melphalan. As supportive therapy, G-CSF and acyclovir were given. For prophylaxis against CMV infection, high CMV-titered gamma globulin was administered at a dose of 250 mg/kg once weekly i.v., and CMV-seronegative blood products were transfused. The serum anti-CMV IgM and IgG of the patient was negative pretransplant. The patient received /kg nucleated cells obtained from her healthy brother's cord blood (CB), which was collected at our institute 6 months before transplant. The anti-CMV titer of the patient's mother suggested past and inactive infection. The CMV state of the CB was not examined. CsA and short-term MTX were administered for the prevention of acute GVHD.
The patient engrafted satisfactorily (neutrophils у0.5 × 10 9 /l on day +24), and had evidence of grade 1 acute GVHD of the skin from day +9 to day +22, which was improved by the administration of oral prednisolone (PSL, 2 mg/kg/day with tapering). However, on day +32 acute cutaneous GVHD recurred to progress to form confluent bullae (stage 4), which improved gradually with methylprednisolone pulse therapy (MPT, methylprednisolone 500 mg/m 2 /day × 3 consecutive days) followed by oral PSL (2 mg/kg/day). On day +40 post-transplant, the patient developed dry cough and expiratory wheezing without fever. CMV antigenemia became positive on day +44, and ganciclovir (GCV) was i.v. administered 5 mg/kg twice daily (Figure 1 ). Although the antigenemia became negative with GCV administration, exertional dyspnea and wheezing with expiratory prolongation developed 3 months after the CBT, which were improved by inhalation of a ␤-adrenergic bronchodilator and anticholinergic aerosol. A chest X-ray showed overinflation without infiltration. Pulse oximetry showed the patient's oxygen saturation was у96% with room air even when the patient was dyspneic. The patient was in the condition of so-called 'pink puffer', suggesting OLD. 5 Chronic GVHD was manifested by signs of patchy skin depigmentation, poor nail growth, and dryness of the eyes. Azathioprine was prescribed at a dose of 1 mg/kg/day. Inspiratory stridor with hoarseness developed 4 months after CBT, and a laryngoscopy revealed no respiratory foreign bodies, croup syndrome, or laryngomalacia. Epinephrine inhalation improved the stridor, and thereafter the patient needed to be treated with epinephrine inhalation on demand. The patient needed to be intubated with positive-pressured mechanical ventilation because of progressive dyspnea and hypercapnia 6 months after the CBT. Arterial blood gas analysis revealed у200 mmHg of pO 2 and 80 mmHg of pCO 2 on 30% O 2 inhalation. The chest X-ray showed expiratory air trapping without infiltration. The patient remained in the 'pink puffer' state. CMV was not detected in the bronchoalveolar lavage fluid. The patient was not extubated because of the progression of emphysematous dyspnea and hypercapnia. An open lung biopsy was performed on day +185 post-transplant, revealing mild interstitial pneumonitis without specific inclusion-bearing cells, a finding which was incompatible with the patient's clinical findings such as emphysema and hypercapnia without hypoxemia. Foscarnet and MPT were given with no subsequent effect. The patient expired on day +199 posttransplant because of progressive respiratory acidosis. The marrow cells of the patient had been donor type after engraftment. Necropsy of the lung was allowed. The gross appearance of the lung was congestive and emphysematous, and multiple nodular hard lesions were noted in the cut sections. Histologic examination revealed bronchiolitis obliterans and interstitial lymphocytic infiltrate. Broncho-bronchiolitis, including the mainstem bronchi, was identified with cicatricial obstructive changes, which surrounded some cytomegalic inclusion cells (Figure 2 ). CMV genomic DNA was detected by in situ hybridization. The parenchyma showed many spotty necrotic and cicatricial regenerative lesions with many cytomegalic inclusion cells. Bacterial and fungal infections were not observed.
Discussion
We have described a patient with fatal OLD after an HLAhaploidentical sibling CBT. Severe cutaneous GVHD was observed, and positive levels of CMV antigenemia in the peripheral blood waxed and waned. Necropsy of the lung identified bronchiolitis, including the mainstem bronchi, with cicatricial obstructive changes and cytomegalic inclusion cells.
GVHD occurs infrequently in patients after CBT because proliferative and cytotoxic responses of CB lymphocytes are blunted compared with adult peripheral lymphocytes. 6 As was seen in the present case, severe GVHD and immunologic problems can occur in CBT, and more investigations will be needed to analyze what degree of HLA disparities is tolerable in CBT.
Many clinicians have been attempting to elucidate the pathogenic mechanism of fatal OLD after BMT. Yousem 7 reviewed 17 lung biopsy specimens showing GVHD in BMT recipients, and proposed that GVHD insults to the lung might lead to a pattern of pulmonary scarring which was localized to the airways and perivascular zones. On the other hand, Müller and coworkers 8 concluded in their review of lung biopsy specimens from 30 allogeneic BMT recipients that CMV pneumonia in BMT recipients was an immunologic disease, with the primary pathologic process being an activated host immune response to the presence of viral antigen in the lung. Based on our analysis of the present case, co-existence of GVHD and CMV infection may have worsened the host's immunologic imbalances of the lung. The histology of the lung revealed bronchiolitis obliterans with peribronchiolar granulation tissues surrounding the CMV inclusion body-containing cells. These findings indicate that the activated immune system might not subside with the elimination of CMV from the body, and scarring and tissue destruction develop due to the chronic inflammation resulting from insufficiently controlled antiviral immune responses, not from the GVHD alone.
With the introduction of CMV-seronegative blood products, the CMV infection rates of CMV-seronegative recipients were reduced to as low as a few percent. 9 However, several of CMV-seronegative recipients pretransplant suffer from CMV disease after engraftment, and there are some pitfalls in the interpretation of the pretransplant CMV serologic data of immunosuppressed patients who have received prior anticancer chemotherapy. For instance, since these patients may not mount a detectable antibody response to CMV, the pretransplant data may mask an underlying CMV infection. In our patient, it is likely that the virus in the host was reactivated in the immunocompromised condition of severe GVHD, although we can not explain it exactly because the CMV status in the infused cord blood was not examined.
In conclusion, we report a case of fatal OLD with severe acute GVHD after HLA-haploidentical CBT, and with coexistent CMV infection identified by necropsy. More attempts should be made to conquer the vicious circle of immunologic disturbances involved in CMV infection, GVHD and immunosuppressive therapy post-transplant.
